Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Paroxysmal Paralytic Rhabdomyolysis via the LPIN1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Paroxysmal Paralytic Rhabdomyolysis via the LPIN1 Gene, Exons 18-19 Deletion PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Metabolic myopathy and rhabdomyolysis panel. NGS panel of 52 genes. Genologica Medica Spain | 89 | 52 |
|
Fatty acid oxidation syndrome panel. NGS panel of 26 genes. Genologica Medica Spain | 30 | 26 |
|
General panel of metabolic myopathies Genologica Medica Spain | 114 | 110 |
|
Duzen Laboratories Duzen BBAGUAS Turkey | 1 | 1 |
|
LPIN1 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
LPIN1 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Congenital Myopathy , Panel Massive Sequencing (NGS) 26 Genes Reference Laboratory Genetics Spain | 24 | 26 |
|
Metabolic Myopathy and Rhabdomyolysis Asper Biogene Asper Biogene LLC Estonia | 63 | 44 |
|
Recurrent Myoglobinuria , Sequencing LPIN1 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Rhabdomyolysis & Metabolic Myopathies NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 46 | 47 |
|
Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 1 | 1 |
|
Institute of Human Genetics Medical University Innsbruck Austria | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fatty Acid Oxidation Deficiency NGS Panel Fulgent Genetics United States | 23 | 22 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Myopathy-Rhabdomyolysis NGS Panel Fulgent Genetics United States | 37 | 29 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.